Drug trial aims to make High-Risk Weight-Loss surgery safer
NCT ID NCT07192640
Summary
This study is testing whether giving a drug called tranexamic acid (TXA) during weight-loss surgery can safely reduce blood loss for high-risk obese patients. It will involve 128 patients with a high body mass index (BMI) and other health conditions like diabetes. The main goal is to see if TXA lowers the need for blood transfusions and reduces complications from bleeding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
King Salman Specialist Hospital, Hail, KSA
Hail, 6539307, Saudi Arabia
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.